All Posts: aging
-
Partners in Research Supports Visionary Scientists
(December 14, 2019) — Research is a chicken-and-egg phenomenon. One thing leads to another. But without investigational funding there is no chicken. And no egg. So says Nady Golestaneh, PhD, MSc, adding that she would not be where she is today in her quest to prevent a common blindness in the elderly without small grants […]
Category: GUMC Stories
-
Heightened Risk of Adverse Financial Changes Before Alzheimer’s Diagnosis
WASHINGTON (October 25, 2019) — Prior to an Alzheimer’s diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes — a likely consequence of compromised decision-making when managing money, in addition to exploitation and fraud by others. That is the disquieting conclusion of a study published in […]
Category: News Release
-
In Times of Low Unemployment, Nursing Home Quality Suffers
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (December 7, 2018) — The low unemployment rate in the U.S. — which fell to a 49-year low in September and October — is good news to many people, but perhaps not to residents of nursing homes. A Georgetown University Medical Center (GUMC) study found that quality of care in nursing homes […]
Category: News Release
-
Mouse Study Mirrors Human Findings That Link Chemotherapy and APOE4 to Cognitive Issues
New research by Georgetown University Medical Center investigators indicates that a chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, which is known to significantly increase the risk of developing Alzheimer’s disease.
Category: News Release
-
First Large Study Details Cognitive Outcomes Among Older Breast Cancer Patients
The first large U.S. study of cognition in older breast cancer patients, led by researchers from Georgetown Lombardi Comprehensive Cancer Center, indicates that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.
Category: News Release
-
Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown
Georgetown University Medical Center announces a clinical trial testing the safety of the repurposed cancer drug nilotinib in Huntington’s disease. This is the fourth clinical trial of the drug for a neurodegenerative disorder.
Category: News Release
-
Georgetown University Medical Center Selected as Lewy Body Dementia Research Center of Excellence
The Lewy Body Dementia Association has designated Georgetown University Medical Center as a “Research Center of Excellence.” GUMC joins 23 other centers chosen for their clinical expertise in Lewy body dementia, experience running clinical trials in related conditions, their facility’s capacity and willingness to participate, and their geographic locations.
Category: News Release
-
Taking a Broad Look at Aging
With collaboration from teaching faculty across the campus, Georgetown University will launch the new master’s in aging & health program in this fall. The new program goes beyond geriatrics to the study of aging well in today’s society.
Category: GUMC Stories
-
Some Cancer Therapies May Provide a New Way to Treat High Blood Pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer an advance in hypertension treatment.
Category: News Release
-
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance. These dual findings, presented by Georgetown University Medical Center (GUMC) researchers at […]
Category: News Release